Drugs / XJ-MK-002
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07110090 | Aug 2025 → Jun 2026 overdue | cancer, thrombocytopenia | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | XJ-MK-002 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07110090 ↗ |
| Known as | Umbilical Cord Blood Megakaryocyte Injection | “Umbilical Cord Blood Megakaryocyte Injection (XJ-MK-002)” NCT07110090 ↗ |
| Route | Intravenous | “following intravenous infusion” NCT07110090 ↗ |